Category: Investor updates

Imagion Biosystems announces the appointment of Oliver Steinbach PhD to the position of Vice President Clinical and Regulatory Affairs. Read the announcement.

“Appendix 3B New issue announcement” has been released by Imagion Biosystems. Read Appendix 3B New Issue Announcement.

Imagion Biosystems has announced the following Response to Price Query with the ASX. Read the Response to Price Query.

The following response to “Appendix 3Y — Change of Director’s Interest Notice Query” has been announced. Read the response.

Imagion Biosystems has released “Notice Pursuant to Section 708A(5)(e) of the Corporations Act.” Read the notice.

Imagion Biosystems has released Appendix 3B: New issue announcement, application for quotation of additional securities and agreement. Read Appendix 3B.

Imagion Biosystems has released Change of Director’s Interest Notices for David Ludvigson, Mark Van Asten, and Robert Proulx. Read the Change in Director’s Interest Notices:

Imagion Biosystems Limited has released “Form 604: Notice of change of interests of substantial holder” to the market. Read Form 604.

Imagion Biosystems Limited has announced “Form 605: Notice of ceasing to be a substantial holder.” Read Form 605.